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Background: Malaria is one of the most important tropical diseases and the greatest cause of hospitalization and
death. Recurring problems of drug resistance are reinforcing the need for finding new antimalarial drugs. In this
respect, natural plant products are the main sources of biologically active compounds and have potential for the
development of novel antimalarial drugs. A study was conducted to evaluate extracts of the leaves of Croton
macrostachyus and Acokanthera schimperi for their in vivo antimalarial activity.
Methods: The plants were selected based on their ethnomedicinal information. Acute and sub- acute toxicity studies
of the crude extracts were carried out in Swiss albino mice. To assess the effect of extracts of the plants on the parasite,
a 4-day suppressive standard test was performed using Plasmodium berghei (ANKA strain). Data were analyzed using
paired t-test and ANOVA.
Results: In acute toxicity study, the two plants extracts did not show any sign of toxicity up to 2000 mg/kg. In sub-acute
toxicity study, both plants did not exhibit any hematological change and mortality throughout the observation period
up to the highest dose of 1000 mg/kg given daily. Extracts of the leaves of both plants significantly (P < 0.05) suppressed
parasitaemia in dose dependent manner at all dose levels.
Conclusions: The findings may support the traditional use of the plants to treat malaria. Further pharmacological,
toxicological and phytochemical studies are, however, required to evaluate the potential of the plants towards the
development of new antimalarial agent.
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Malaria is a major public-health problem in the world;
transmission primarily being common in tropical and sub-
tropical regions [1]. According to WHO, globally, there
were about 216 million and 207 million cases of malaria in
2010 and 2012, respectively, and estimated 655,000 and
627,000 deaths in 2010 and 2012, respectively [2,3].
In Ethiopia, though some improvements were recently
achieved, malaria is still the leading cause of morbidity
and mortality [4,5]. Ethiopia is also one of the most mal-
aria epidemic-prone countries in Africa where rates of
morbidity and mortality increase 3–5 folds during epi-
demics [6].* Correspondence: mirutseg@yahoo.com
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article, unless otherwise stated.Multi-drug resistant strains of the parasite to antimalar-
ial drugs proved to be a challenging problem in malaria
control in most parts of the world [1]. These recurring
problems render development and promotion of phyto-
medicines as alternative solution to malaria control [7].
Medicinal plants have been playing a vital role in the treat-
ment of malaria for centuries [8] and have always been
considered to be a possible alternative and rich source of
new drugs. Today, herbal products are being used world-
wide in a variety of healthcare settings, and as home rem-
edies [9]. Over 1200 plant species from 160 families are
used to treat malaria and fever in endemic countries [10].
It is estimated that about 80% of the population in
Ethiopia is still dependent on traditional medicines [11].
However, scientific studies on the status of use of phyto-
medicine, preparation of crude extracts and isolation ofntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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chyus and Acokanthera shimperi are two of the plants that
are traditionally used for malarial treatment in Ethiopia
[13,14]. A study reported that methanol extracts of the
fruits of C. macrostachyus have shown substantial anti-
malarial activities against P. falciparum in vitro with IC50
value of 0.94 μgm/mL [15]. An in vivo study also showed
that methanol extract of the fruits of Croton macrostachyus
has significant suppressive effect against P. berghei [16]. An
in vivo study conducted on Acokanthera oppositifolia in
Kenya and in vitro study conducted on Croton zambesicus
in Cameroon, taxonomically related species to A. schimperi
and C. macrostachyus, respectively, demonstrated an
interesting antiplasmodial activity on P. falciparum
[17,18]. The objective of this study, therefore, was to
investigate antimalarial effect of aqueous and metha-
nol extracts of the leaves of A. schimperi and C. macrosta-
chyus in mice infected with chloroquine sensitive strain of
P. berghei. The study was conducted at the Endod and
Other Medicinal Plants Research Unit of the Aklilu
Lemma Institute of Pathobiology, Addis Ababa University.
Methods
Plant material collection sites
Young leaves of Acokanthera schimperi were collected
from Bishan Gari Lodge area (Buku Wolda) about 20 km
off the Addis Ababa – Hawasa road in December 2012
(reference number TM02-2012) and that of Croton
macrostachyus from the compound of the Aklilu Lemma
Institute of Pathobiology (ALIPB) in October, 2012 (ref-
erence number: TM01-2012). The plants were identified
by the second author, the botanist at the Aklilu Lemma
Institute of Pathobiology, Addis Ababa University, and
voucher specimens were deposited at the Institute. The
plants were selected based on previous reports of their
traditional use for treating malaria in Ethiopia [13,14].
Preparation of crude plant extracts
The leaves of Acokanthera schimperi and Croton macrosta-
chyus were washed thoroughly with running tap water and
each plant material was reduced to small fragments. The
plant samples were air-dried at room temperature under
shade, and ground into powder using pestle and mortar.
The powdered plant materials were packed in plastic bags
until extraction. The coarsely powdered plant materials were
weighed using sensitive balance and repeatedly extracted in
water and methanol in maceration flasks. Powdered plant
parts (140 gm of Croton macrostachyus and 155 gm of
Acokanthera schimperi) were mixed in distilled water and
methanol separately in 1:10 (w/v) and placed on orbital
shaker at 130 rpm for 24 hours in water and for 72 hours in
methanol at room temperature. Then, the extracts, were fil-
tered through Whatman (no 1, diameter 150 mm, England).
The methanol extract was concentrated at 40°C with arotary evaporator (Buchi, Switzerland) in distillation flask to
eliminate methanol from the crude extract and concen-
trated further to dryness in a water bath at 40°C. For aque-
ous extract, residual water was removed by lyophilizer
(Heto Power Dry LL3000, Wagtech, Denmark) at −56°C.
Then, the extracts were stored in tightly closed bottle con-
tainers in a refrigerator at 4°C until they were used for the
experiment [19-21].
Experimental animals and parasite inoculation
Experimental animals and parasite strain
Male Swiss albino mice, 5–7 weeks of age and 23–38 gm
of weight were obtained from the Ethiopia Health and
Nutrition Research Institute (EHNRI). They were kept in
the animal care facility of the Aklilu Lemma Institute
Pathology, Addis Ababa University, for one week prior
to the initiation of the experiments for acclimatization
to laboratory conditions. The mice were kept at room
temperature in humid environment and were exposed to
12 hours light and 12 hours darkness. The mice were given
water and standard food pellets every 24 hours. In vivo anti-
malarial testing in mice was done using chloroquine sensi-
tive strain of Plasmodium berghei (ANKA strain) obtained
from EHNRI. On weekly basis, the parasites were main-
tained by serial passage of blood from infected mice having
a parasitamia level of 20-30% to non-infected ones.
Parasite inoculation
Albino mice previously infected with P. berghei were used as
donor animals. The parasitaemia of the donor mice was first
determined and parasitized erythrocytes were obtained by
cardiac puncture using ethyl ether as anesthesia and diluted
in physiological saline (0.9%). The dilution was made based
on the parasitaemia of the donor mice and the RBC count
of normal mice in such a way that 1 mL blood contains
5 × 107 infected erythrocytes [22]. Each mouse was in-
oculated by intraperitoneal injection with a blood suspen-
sion (0.2 mL) containing 1 × 107 parasitized erythrocytes.
In vivo toxicity test of the crude plant extracts
The crude methanol and aqueous extracts of Croton
macrostachyus and Acokanthera schimperi intended for
the antimalarial test against P. berghei were evaluated for
their acute toxicity in non-infected Swiss albino mice
aged 6–8 weeks and weighing 23-38 g. For each extract,
10 mice were used by randomly dividing them into two
groups of 5 mice per group. The mice were starved 3–4
hours before the experiment began with only water
allowed and 1–2 hours after the extract was given [23].
Then, the mice in group 1 were given orally 0.2 mL of
2000 mg/kg body weight of the extract in single dose in
dH2O. The mice in the control groups received 0.2 mL
of vehicle of the extract (dH2O). Then, the mice were
observed continuously for 30 minutes, followed by 4
% Parasitaemia ¼ Number of Parasitized RBC  100
Total RBC counted
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next 13 days, for any manifestation of toxicity [23].
For sub-acute toxicity studies, weight and haematological
parameters were determined before and after treatment.
These include, packed cell volume (PCV), white blood cells
count (WBC) and haemoglobin (Hb). A hand-held scale
reader for PCV, Hemacytometer (Hawksley improved
neubauer double cell) for WBC and haemoglobin meter
(HemoCue model 201+, Angelholm, Sweden) for Hb were
used for the determination. The extracts in each case were
administered orally for four days (i.e. D0 to D4) using
gavages [23]. The mice were grouped randomly, five mice
per group. The mice in group I, II and III were given orally
500, 750 and 1000 mg/kg body weight in single dose vol-
ume of 0.2 mL of each extract, respectively and control
group received 0.2 mL of dH2O. The data was recorded
on day 0 and day 4 (12 hours after administration of the
last dose) with regards to reduction in PCV and Hb, weight
losses and WBC, following which, the mice were closely
observed for one month.In vivo antimalarial screening
Schizontocidal activity was evaluated by the 4-day suppres-
sive standard test [24]. Male Swiss albino mice weighing
24–35 grams were randomly divided into five groups of five
mice per cage for each extract. All mice were infected with
P. berghei on the first day (D0). Treatment commenced
3 hours after infection on day 0 and then continued daily
for four days (i.e. from day 0 to day 3).The mice in the three
treatment groups received extract from the Acokanthera
schimperi and Croton macrostachyus 0.2 mL (200 mg/kg,
400 mg/kg, and 600 mg/kg) of each extract. Group IV
(negative control) received the vehicle (dH2O), while
the fifth group received the standard antimalarial drug
(chloroquine) 25 mg/kg, with the same amount of volume
(0.2 mL), daily for 4 days. The plant extracts and the stand-
ard drug were administered through intragastric route
using standard tube to ensure safe ingestion of the ex-
tracts and the drug [23]. On the fifth day (D4), blood
samples were collected from tail snip of each mouse
[25] and thin smears were prepared and stained with
10% Giemsa solution. Then, the slides were examined
under the microscope and parasitaemia determined by
counting minimum of five fields per slide (500 RBC),
for negative smear up to 100 field [26]. The smears
were counted blindly by technician. Percent parasit-
aemia and percentage of suppression was calculated
using the formula indicated in [19,27].% Suppression ¼ Parasitaemia in negative control−
parasitaemia in treated group 100
Parasitaemia in negative controlIn acute toxicity testing, change in body weight of in-
dividual mice was determined and recorded before and
after extract administration [23], while evaluation of
antimalarial activity and sub toxicity testing, body weight
of each mouse was measured before infection (day 0)
and continuously for four days.
Packed cell volume measurement was done before in-
fection on day 0 and on day 4. Blood was collected from
tail of each mouse in heparinized microhaematocrit ca-
pillary tubes filled up to 3/4th of their length. Then, the
blood was centrifuged using microhematocrit centrifuge
at 12,000 rpm for 5 minutes [28] and measured using a
hand scale reader.
In addition, mortality of mice was monitored daily and
the number of days was recorded for each mouse in the
treatment and control groups throughout the follow up
period.
Data analysis
Data were analyzed using computer software SPSS, ver-
sion 16. Results of the study were expressed as a mean ±
standard error of the mean (M ± SEM). Statistical signifi-
cance was determined by one way analysis of variance
(ANOVA) with multiple comparison tests (Post Hoc/
Tukey’s test/HSD) to compare parameters within groups.
Two tailed paired t-test was used to compare mean
PCV, Hb, WBC and body weight before and after treat-
ment. All data were analyzed at a 95% confidence
interval (α = 0.05).
Ethical consideration
The study obtained ethical clearance from Institutional
Review Board (IRB) of Aklilu Lemma Institute of Photo-
biology, Addis Ababa University. The mice were handled
in humane accordance to the National Guidelines for
handling laboratory animals for its scientific and academic
merits.
Results
Extraction yield of plants
The methanol and aqueous extracts of Acokanthera
schimperi showed the highest yield with 37.4% and 23.4%,
followed by methanol extract of Croton macrostachyus
with 17.42% and that of water extract 4.6%.
Acute toxicity test
In the in vivo acute toxicity studies of the plant extracts,
there were no gross physical and behavioral changes; in-
cluding, rigidity, sleep, diarrhea, depression, abnormal
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ity occurred within the observation period of two weeks.
Sub-acute toxicity test
Methanol and aqueous extracts of Croton macrostachyus
on day 4 showed no statistically significant difference
(P > 0.05) in all the hematological parameters men-
tioned above as compared to that of day 0 (Table 1). No
mortality was observed in all treatment groups of both ex-
tracts and there was no statistical significant difference
(P > 0.05) on body weight in methanol extract. Though,
significant (P < 0.05) bodyweight loss at the highestTable 1 Sub-acute toxicity effects of methanol and aqueous e
Extract Dose Parameters
































The results are expressed as mean ± SEM (n = 5); NC = negative control; PCV = packe
not significant.dose i.e. 1000 mg/kg (from 30.20 gm to 25.90 gm) and
body weight gain at 500 mg/kg (from 31.34gm to 33.58
gm) in aqueous extract and in negative control group
(from 26.54 gm to 29.36 gm) was observed.
In sub-acute toxicity studies of methanol and water
extracts of A. schimperi, when day 4 was compared to
day 0 at a given dose levels (500,750,1000 mg/kg), no
mortality was observed in any treatment group (Table 2).
There was no significant difference (P > 0.05) observed
on hematological parameters (PCV and Hb) and in the
body weight of animals treated with both extracts and
control group.xtracts of Croton macrostachyus
Day 0 Day 4 P-Value
33.00 ± 2.59 32.34 ± 2.91 0.628
54.60 ± 1.29 54.20 ± 1.62 0.840
7360 ± 1591.34 10300 ± 250.49 0.114
not determined not determined
34.66 ± 2.29 35.92 ± 2.13 0.085
51.60 ± 0.93 50.20 ± 0.66 0.404
5180.00 ± 908.93 7470.00 ± 314.88 0.720
not determined not determined
36.56 ± 1.10 33.14 ± 1.76 0.124
52.20 ± 1.96 52.20 ± 0.86 0.852
9420.00 ± 489.03 9840.00 ± 1259.41 0.647
not determined not determined
35.86 ± 0.56 40.12 ± 0.97 0.007
52.00 ± 0.89 52.40 ± 0.60 0.587
9700 ± 921.95 5500 ± 916.79 0.004
not determined not determined
31.34 ± 0.56 33.58 ± 0.72 0.002
55.4 ± 1.50 50.80 ± 2.33 0.079
5530.00 ± 501.65 8870.00 ± 1750.90 0.152
not determined not determined
31.94 ± 1.09 29.12 ± 2.02 0.072
55.00 ± 1.18 53.60 ± 0 .87 0.245
9760.0 ± 932.12 13610 ± 1581.41 0.72
not determined not determined
30.20 ± 1.49 25.90 ± 2.38 0.018
55.40 ± 2.14 57.60 ± 1.12 0.282
4700.00 ± 470.11 9730.00 ± 1503.46 0.53
not determined not determined
26.54 ± 1.16 29.36 ± 1.52 0.021
54.60 ± 0.75 47.40 ± 0.81 0.007
9630 ± 1260.22 8000 ± 1832.01 0.54
not determined not determined
d cell volume: WBC = white blood cells; Hb = haemoglobin; P > 0.05 is
Table 2 Sub-acute toxicity effects of methanol and aqueous extracts of Acokanthera schimperi
Extract Dose Parameters Day 0 Day 4 P-Value
Methanol 500 mg Body weight (gm) 31.74 ± 2.16 33.76 ± 2.08 0.162
PCV (%) 54.60 ± 0.75 52.80 ± 1.50 0.195
WBC not determined not determined
Hb (g/dL) 16.36 ± 0.55 15.38 ± 0.43 0.052
750 mg Body weight (gm) 30.38 ± 0.59 31.68 ± 0.84 0.094
PCV (%) 55.40 ± 0.40 50.20 ± 2.18 0.057
WBC not determined not determined
Hb (g/dL) 17.10 ± 0.32 16.32 ± 0.63 0.074
1000 mg Body weight (gm) 32.22 ± .1.54 31.70 ± 1.72 0.073
PCV (%) 52.40 ± 0.75 49.80 ± 2.04 0.395
WBC not determined not determined
Hb (g/dL) 16.46 ± 0.27 14.68 ± 0.63 0.109
NC Body weight (gm) 29.04 ± 1.82 30.80 ± 1.59 0.078
PCV (%) 52.40 ± 0.98 51.20 ± 1.07 0.109
WBC not determined not determined
Hb (g/dL) 16.58 ± 0.79 15.48 ± 0.65 0.097
Aqueous 500 mg Body weight (gm) 30.42 ± 1.45 31.52 ± 1.30 0.327
PCV (%) 53.30 ± 1.41 50.20 ± 0.66 0.156
WBC not determined not determined
Hb (g/dL) 16.66 ± 0.38 14.86 ± 0.35 0.052
750 mg Body weight (gm) 31.34 ± 2.34 31.88 ± 2.11 0.573
PCV (%) 53.10 ± 1.33 49.40 ± 1.25 0.083
WBC not determined not determined
Hb (g/dL) 16.30 ± 0.72 14.96 ± 0.77 0.123
1000 mg Body weight (gm) 31.60 ± 2.36 32.90 ± 2.21 0.147
PCV (%) 54.48 ± 0.96 51.20 ± 2.15 0.227
WBC not determined not determined
Hb (g/dL) 17.10 ± 0.51 15.54 ± 0.43 0.123
NC Body weight (gm) 29.04 ± 1.82 30.80 ± 1.59 0.078
WBC not determined not determined
PCV (%) 52.40 ± 0.98 51.20 ± 1.07 0.109
Hb (g/dL) 16.58 ± 0.79 15.48 ± 0.65 0.097
The results are expressed as mean ± SEM (n = 5); NC = negative control; PCV = packed cell volume; WBC = white blood cells; Hb = haemoglobin; P > 0.05 is
not significant.
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Effect of crude extracts on PCV and body weight
Methanol and aqueous extracts of Croton macrostachyus
did not prevent PCV reduction due to parasitemia.
Significant reduction of PCV on day 4 as compared to
day 0 (p < 0.05) was observed in both treatment and in
negative control groups. But, no significant (p > 0.05)
change was observed in body weight of all groups. For
chloroquine treatment groups, no significant change
(P > 0.05) was observed in all parameters (Table 3).
PCV and body weight measurements on day 4 indi-
cated that both methanol and aqueous extracts ofAcokanthera schimperi prevented significantly (P < 0.05)
PCV reduction and body weight loss at all dose levels
(200 mg, 400 mg, 600 mg) due to parasitemia. In negative
control, there was significant (P < 0.05) reduction in PCV
on day 4, though no bodyweight change observed (Table 4).
Effect of crude extracts of leaves of Croton macrostachyus
and Acokanthera shimperi on parasitaemia and mean
survival time of mice
Methanol and aqueous extracts of Croton macrostachyus
and Acokanthera shimperi showed dose dependent chemo-
suppressive effect at various doses in mice infected with







PCV Body weight in grams
Day0 Day4 Day0 Day4
Methanol extracts 200 54.60 ± 0.51 45.60 ± 1.17 a 30.06 ± 0.50 30.06 ± 0.61*
400 55.70 ± 0.30 46.00 ± 2.98 a 29.68 ± 0.51 28.68 ± 0.10*
600 54.68 ± 0.63 46.00 ± 1.30 a 30.60 ± 1.55 30.04 ± 1.43*
Distilled water 1 mL 55.00 ± 0.84 44.00 ± 1.80 a 28.78 ± 1.10 28.18 ± 1.07*
Chloroquine 25 53.20 ± 1.59 49.00 ± 1.09* 29.96 ± 0.62 29.80 ± 0.66*
Aqueous extracts 200 55.60 ± 0.24 43.20 ± 3.18 a 30.20 ± 1.75 28.18 ± 1.07*
400 55.60 ± 0.24 45.60 ± 1.36 a 28.32 ± 1.60 28.66 ± 2.26*
600 55.60 ± 0.24 45.00 ± 1.92 a 29.00 ± 0.95 28.48 ± 1.65*
Distilled water 1 mL 55.00 ± 0.84 44.00 ± 1.80 a 28.78 ± 1.10 28.18 ± 1.07*
Chloroquine 25 53.20 ± 1.59 49.00 ± 1.09* 29.96 ± 0.62 29.80 ± 0.66 *
Results presented as mean ± SD; n = 5; * = there was no significant difference, between Day-0 and Day-4 (P > 0.05); a = there was a significant difference between
Day-0 and Day-4 (P < 0.05).
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quine were completely free from the parasites on day four
in all the experiments.
The crude methanol extracts of Croton macrostachyus
significantly suppressed (P < 0.05) parasitaemia at all
dose levels compared to the negative control groups
but did not improve survival time significantly (P > 0.05)
(Table 5).
Similarly, the aqueous extracts of Croton macrostachyus
significantly reduced parasitaemia compared to the
negative control group. The highest significant parasit-
aemia suppression (P < 0.05) was observed for this ex-
tract although it did not improve the mean survival
time (Table 6).
Tables 7 and 8 show a summary of parasitaemia sup-
pression (%) of A. schimperi for mice on day 4. BothTable 4 Effect of crude methanol and aqueous leaf extracts o







Methanol extracts 200 55.80 ± 0.37
400 53.60 ± 0.40
600 55.20 ± 0.37
Distilled water 1 mL 55.20 ± 1.11
Chloroquine 25 54.00 ± 1.14
Aqueous extracts 200 53.60 ± 1.50
400 54.00 ± 1.14
600 52.20 ± 1.24
Distilled water 1 mL 55.20 ± 1.11
Chloroquine 25 54.00 ± 1.14
Results presented as mean ± SD; n = 5;* = there was no significant difference betwe
Day-0 and Day-4 (P < 0.05).aqueous and methanol extracts showed significant sup-
pression of parasitaemia (P < 0.05). The mean survival
time of treatment group ranged from 7.00 ± 1.73 up to
10.60 ± 0.51 days, whereas that of negative control was
6.2 ± 0.20 days. The mice treated with the methanol
and aqueous extracts at 600 mg/kg survived longer
(10.60 ± 0.51 days for methanol extract and 9.60 ±
0.51 day for aqueous extract) than those in the negative
control group with mean survival time of 6.2 ± 0.20 days
(P < 0.05).
Discussion
In this study, the suppressive tests of extracts of the leaves
of Acokanthera schimperi and Croton macrostachyus dem-
onstrated a significant dose dependent chemosuppressive
effect at various doses (200,400,600 mg/kg) for aqueousf Acokanthera schipmeri on body weight and PCV of
CV Body weight in grams
Day 4 Day 0 Day 4
49.20 ± 2.71* 29.20 ± 1.22 29.08 ± 1.09*
52.80 ± 1.50* 31.82 ± 2.036 31.34 ± 2.34*
46.20 ± 3.39* 29.98 ± 1.63 29.88 ± 0.89*
37.00 ± 2.94a 29.64 ± 1.99 26.96 ± 2.26*
55.60 ± 1.50* 28.20 ± 1.79 28.68 ± 2.10*
49.20 ± 1.80* 28.80 ± 1.53 28.90 ± 1.55*
48.60 ± 1.69* 29.78 ± 2.08 28.14 ± 1.61*
45.20 ± 2.92* 30.24 ± 1.48 28.52 ± 1.48*
37.00 ± 2.94a 29.72 ± 1.95 26.90 ± 2.28*
55.60 ± 1.50* 28.20 ± 1.79 28.68 ± 2.10*
en Day-0 and Day-4 (P > 0.05); a = there was a significant difference between
Table 5 Suppressive effect of methanol extracts of Croton macrostachyus and mean survival time




% Parasitaemia ± SEM % Suppression
1 Distilled water (1 mL) 46.86 ± 1.03 0.00 7.20 ± 0.37
2 200 38.56 ± 3.07 21.06 7.80 ± 0.58b
3 400 33.88 ± 5.75 27.72 7.40 ± 0.98b
4 600 30.80 ± 5.56 34.33 7.40 ± 0.93b
5 Chloroquine (25) 0.00 100.00 11.75 ± 0.48*
% parasitaemia and mean survival time results presented as mean ± SD; n = 5; * = values are significantly different from that of the negative control; values with
Superscript b- are not significantly different from that of the negative control (P > 0.05).
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pression was exhibited by the aqueous extract of Croton
macrostachyus, followed by the methanol extract of
A. schimperi at 600 mg/kg.
Acute and sub-acute test results of the extracts of both
plant species showed no sign of toxicity in all treated
mice. The 4-day suppressive test is a standard test com-
monly used for antimalarial screening [24]. Extracts of
C. macrostachyus and A. schimperi produced significant
chemosuppression in all treated groups.
Antiplasmodial activity has been related to a range of
several classes of secondary plant metabolites including
alkaloids, sesquiterpenes, triterpenes, flavanoids, limonoids,
quassinoids, xanthones, quinines and phenolic compounds
of which alkaloids have been the most important and have
shown very interesting activities [8,29]. Indeed, quinine is
the first antimalarial drug that belongs to the class of
alkaloids [30] Croton spp. generally contain diterpenoids,
triterpenoids, alkaloids, flavonoids, lignoids and proantho-
cyanidins [31], which have strong antiplasmodial activity.
Therefore, the antiplasmodial activity observed in this
study may be attributed to the presence of these bioactive
compounds.
Both the methanol and aqueous extracts of C. macro-
stachyus exhibited comparable suppressive effect on P.
berghei. However, aqueous extract of Acokanthera
schimperi in all doses tested may be considered to
have lower activity i.e. 22.34%, 22.72% and 24.60%Table 6 Suppressive effect of aqueous extract of Croton macr
Group Dose (mg/kg) Antimalarial acti
% Parasitaemia ±
1 Distilled water (1 mL) 46.89 ± 1.03
2 200 34.24 ± 5.16
3 400 32.60 ± 4.50
4 600 23.20 ± 7.87
5 Chloroquine (25) 0.00
% parasitaemia and mean survival time results presented as mean ± SD; n = 5; * = v
Superscript b- are not significantly different from the negative control (P > 0.05).parasitaemia reduction at 200, 400 and 600 mg/kg, re-
spectively. On the other hand, methanol extract can
be considered active with 34.8% parasitaemia reduc-
tion at 600 mg/kg and 31.8% at 400 mg/kg. Thus, the
result of this study may justify the traditional use of
the plant for antimalarial therapy in different parts of
Ethiopia [13,14].
Methanol and aqueous extract of C. macrostachyus
and A. schimperi prevented body weight loss. Result of
similar study on crude extracts and solvent fractions of
Croton macrostachyus revealed the significant prevention
of weight loss associated with increase in parasitemia
level [32].
Hematological abnormalities are considered a hallmark
of malaria [33]. According to Iyawe and Onigbinde [34],
Plasmodium berghei increases erythrocyte fragility and
significantly reduces PCV in mice. Methanol and aqueous
extracts of A. schimperi prevented PCV reduction in a
dose dependent manner as compared to negative control
group.
Another parameter used to evaluate the efficacy of anti-
malarial plant extracts in this study was mean survival
time. A. schimperi significantly prolonged mice survival
time compared to negative control group at 600 mg/kg
and this could be attributed to parasitemia suppression ef-
fect of the extract of the plant. In contrast, all the doses of
C. macrostachyus, which showed higher parasitemia sup-
pression in this study, did not prolong mean survival time.ostachyus and mean survival time





0.00 7.20 ± 0.20
26.14 7.40 ± 0.98b
30.50 7.80 ± 0.37b
50.53 7.40 ± 0.60b
100.00 11.75 ± 0.48*
alues are significantly different from that of the negative control; values with
Table 7 Parasitaemia suppressive effect of methanol extract of Acokanthera schimperi and mean survival time




% Parasitaemia ± SEM % Suppression
1 Distilled water (1 mL) 52.80 ± 4.24 0.00 6.2 ± 0.20
2 200 40.80 ± 3.67 22.7 7.00 ± 1.73b
3 400 36.00 ± 4.74 31.8 7.20 ± 1.3b
4 600 34.40 ± 2.87 34.8 10.60 ± 0.51*
5 Chloroquine (25) 0.00 100.0 14.2 ± 1.30*
% parasitaemia and mean survival time results presented as mean ± SD; n = 5; values with superscript b are not significantly different from that of the negative
control (P > 0.05).*Values are significantly different as compared to that of negative controls (P < 0.05).
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plasma metabolism is shorter [35].
Comparatively, the methanol extract of the leaves of
C. macrostachyus showed lower antimalarial activity
than its water extract counterpart. On the other hand,
water extract of the leaves of Acokanthera schimperi
showed lower activity compared to that of methanol.
During extraction, solvents diffuse into the solid plant
material and solubilize compounds with similar polarity
[21]. This might indicate that the active compounds
solubility which is responsible for the observed activity
is different.
Chloroquine phosphate used in this study suppressed
parasitaemia to non-detectable number, which is in agree-
ment with [36] in which standard antimalarial drug
cleared P. berghei, to undetectable level. The results of the
acute toxicity within 24 hours revealed that no toxic effect
or mortality was observed in mice treated orally with
methanol and aqueous extracts of Croton macrostachyus
and Acokanthera schimperi as a single dose of 2000 mg/
kg, which the single highest dose is recommended by
OECD Guidelines 425 for testing acute toxicity. In
addition, no changes in general appearance or behavioral
pattern were noted until the end of 14 days. Therefore, ab-
sence of mortality up to an oral dose of 2000 mg/kg could
indicate that the test extracts are safe and this could in
turn explain the safe use of the plants by local people in
Ethiopia who have been using them in traditional manage-
ment of malaria [13,14].Table 8 Parasitaemia suppressive effect of aqueous extract of
Group Dose (mg/kg) Antimalarial activ
% Parasitaemia ±
1 Distilled Water (1 mL) 52.80 ± 4.24
2 200 41.0 ± 3.89
3 400 40.80 ± 1.65
4 600 39.80 ± 3.49
5 Chloroquine (25) 0.00
% parasitaemia and mean survival time results presented as mean ± SD; n = 5; value
(P > 0.05).* = there was a significant difference compared to negative controls (P < 0The median lethal oral dose (LD50) is greater than
2000 mg/kg if three or more animals survive [23]. No
death was observed in the animals receiving the ex-
tracts up to a dose of 2000 mg/kg body weight, which
is about 10 times the minimum effective dose tested
(200 mg/kg). If a test substance has LD50 higher than
three times the minimum effective dose, it can be
taken as a good candidate for further studies [26]. The
extracts from this study are, therefore, good candidates
for further studies.
Repeated dose toxicity studies provide information on
the possible health hazards likely to arise from repeated
exposure over a relatively limited period of time [37]
and repeated daily dosing is more clinically relevant than
acute toxicity study. In this study, a 4-day administration
of the extracts of 500, 750 and 1000 mg/kg daily re-
vealed no sign of toxicity and all mice survived beyond
the 30-days observation period.
According to Pillai et al. [38], the reduction in body
weight is a simple and sensitive index of toxicity after
exposure to toxic substances. In this study, there was no
significant body weight change for aqueous and metha-
nol extracts of A. schimperi and methanol extract of
C. macrostachyus. Nevertheless, body weight loss in
mice was observed at 1000 mg/kg in those treated with
aqueous extract of C. macrostachyus. The decrease in
body weight observed in the group treated with the
highest dose could be attributed to the suppression of
the animals’ appetite by the extract.Acokanthera schimperi and mean survival time
ities on Day-4 post infection Mean survival
SEM % Suppression Time in days
0.00 6.20 ± 0.20
22.34 6.40 ± 0.25b
22.72 7.00 ± 0.77b
24.60 9.60 ± 0.51*
100.00 14.20 ± 0.58*
s with Superscript b are not significantly different from the negative control
.05).
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be used to determine the extent of deleterious effect of
foreign compound including plant extracts on the blood
constituent of an animal. The hematological parameters
of treated mice (Hb and PCV of A. schimperi and PCV
of C. macrostachyus), an index of anemia, did not show
significant difference on day 4 compared to day 0. Simi-
larly, WBC, in case of C. macrostachyus treated mice,
which is an important index of pathological and physio-
logical status [28], exhibited no significant difference. This
effect of the extract on the hematological parameters of
the animals might be an indication that it is unlikely to be
toxic.
Conclusions
The antimalarial activity test showed that both plants
exhibited significant antiplasmodial activity as evidenced
by their ability to suppress P. berghei infection in mice in
a dose dependent manner, which may partly justify the
claim by traditional practitioners about the use of these
two plants against malaria. The study also revealed that
the two plants are not toxic in both acute and sub-acute
tests at the tested doses of the extracts. Further evaluation
of these plants is, however, needed to isolate, identify and
characterize the active ingredients responsible for the ob-
served antimalarial activity of the plants.
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